Travere Therapeutics stock hits 52-week high at 61.76 USD
Travere Therapeutics stock hits 52-week high at 61.76 USD
Profit by knowlytics
Travere Therapeutics stock hits 52-week high at 61.76 USD
Freshpet Q2 2026 slides: volume growth powers beat, raised targets
Insulet Corporation stock hits 52-week low at $127.56
BrightView Holdings stock hits 52-week low at 11.06 USD
Extreme Networks FY26 slides: AI platform drives growth amid cautious outlook
Prudential Financial stock hits 52-week high at $124.95
Global Payments Q2 2026 slides: solid execution amid travel headwinds
Global-E Online stock hits 52-week high at $42.11
Insulet Q2 2026 slides show growth amid retention challenges
Dynatrace Q1 FY27 slides: ARR tops $2B, autonomous operations era begins